Cart
sales@molnova.com
Necroptosis-IN-1
CAS No. 1391980-92-9
Necroptosis-IN-1( —— )
Catalog No. M23550 CAS No. 1391980-92-9
Necroptosis-IN-1 is a potent necroptosis inhibitor of RIPK1. It is an analog of Necrostatin-1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 144 | In Stock |
|
| 5MG | 113 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 318 | In Stock |
|
| 50MG | 440 | In Stock |
|
| 100MG | 625 | In Stock |
|
| 200MG | 823 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNecroptosis-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionNecroptosis-IN-1 is a potent necroptosis inhibitor of RIPK1. It is an analog of Necrostatin-1.
-
DescriptionNecroptosis-IN-1 is a potent necroptosis inhibitor of RIPK1. It is an analog of Necrostatin-1.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetRIP kinase
-
RecptorRIPK1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1391980-92-9
-
Formula Weight263.68
-
Molecular FormulaC12H10ClN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 249 mg/mL (944.32 mM; Need ultrasonic)
-
SMILESO=C(C(Cc(c1ccc2)c[nH]c1c2Cl)N1)NC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jenny L Maki, et al. Fluorescence polarization assay for inhibitors of the kinase domain of receptor interacting protein 1. Anal Biochem. 2012 Aug 15;427(2):164-74.
molnova catalog
related products
-
RIPK1-IN-7
RIPK1-IN-7 is a potent and selective inhibitor of RIPK1(Kd of 4 nM and an enzymatic IC50 of 11 nM),andexhibits excellent antimetastasis activity in the experimental B16 melanoma lung metastasis model.
-
Necrostatin-34
Necrostatin-34 is a RIPK1 kinase inhibitor, stabilizing RIPK1 kinase in an inactive conformation by occupying a distinct binding pocket in the kinase domain.
-
CSLP37
CSLP37 (RIPK2 inhibitor CSLP37) is a novel potent, ATP pocket-binding RIPK2 inhibitor with IC50 of 16.3 nM in ADPGlo assay.
